| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC71330 | Auriculasin | Auriculasin is a nature product isolated from Limonium leptophyllum. Auriculasin has activity toward cannabinoid receptor type 1 (CB1) with an IC50 value of 8.92 µM. |
|
| DC71331 | KM-233 | KM-233 is a classical cannabinoid with good blood brain barrier penetration. KM-233 possesses a selective affinity for the CB2 receptors relative to THC. KM-233 is effective at reducing U87 glioma tumor burden, and can be used for glioma research. |
|
| DC71332 | (R)-SLV 319 | (R)-SLV 319 is a potent and selective cannabinoid receptor 1 (CB1) antagonist with a Ki value of 894 nM. (R)-SLV 319 is a dextrorotatory counterpart of SLV 319 |
|
| DC71518 | AM8936 | AM8936 acts as a balanced and potent cannabinoid receptor type-1 (CB1) agonist in functional assays (EC50s of 8.6 and 1.4 nM for rCB1 and hCB1, respectively). AM8936 exhibits high affinity for rat CB1 (rCB1) with Ki of 0.55 nM. AM8936 is a potent and efficacious CB1 agonist in vivo. AM8936 can be used for the research of CNS and metabolic disorders, pain, glaucoma, etc. |
|
| DC71767 | CB1R Allosteric modulator 3 | CB1R Allosteric modulator 3 is a CB1R positive allosteric modulator. CB1R Allosteric modulator 3 has potent inhibition of cAMP and β-Arrestin with EC50 values of 0.018 μM and 1.241 μM, respectively. |
|
| DC71768 | COR170 | COR170 (11u) is a selective CB2 inverse-agonist which is a 4-quinolone-3-carboxylic acid derivative with a Ki value of 3.8 nM for CB2 receptor. COR170 can be used for the research of inflammation and neuroprotection. |
|
| DC72186 | ANEB-001 | ANEB-001 is an orally active CB1 inhibitor, can be used to research acute cannabinoid intoxication. |
|
| DC72620 | GW 833972A | GW 833972A is a selective CB2 receptor agonist. GW 833972A inhibits induced nerve depolarization and citric acid-induced cough in animal models. |
|
| DC72621 | Pirnabine | Pirnabine is a cannabinoid receptor ligand. Pirnabine can be used for the research of glaucoma. |
|
| DC72907 | CB-25 | CB-25 is a ligand of CB1 cannabinoid receptors, acting as a partial agonist. CB-25 enhances Forskolin-induced cAMP formation in cancer cells but not hCB1-CHO cells. |
|
| DC73386 | AM6527 | AM6527 is a highly potent, selective cannabinoid CB1 receptor antagonist with binding Ki of 4.88 nM, 100-fold selective over CB2 receptors. |
|
| DC73387 | JM-00266 | JM-00266 is a novel non-brain penetrant cannabinoid receptor 1 (CB1R) inverse agonist. |
|
| DC73388 | JWH133 | JWH133 (JWH-133) is a potent and selective CB2 agonist with Ki of 3.4 nM, 200-fold selective over CB1 receptors, inhibits glioma growth in vivo. |
|
| DC73389 | LEI-102 | LEI-102 (LEI 102) is a potent, selective cannabinoid CB2 receptor agonist with binding pKi of 8.0, 1000-fold selectivity over CB1R. |
|
| DC73390 | URB447 | URB447 (URB-447) is a peripherally restricted CB(1) antagonist/CB(2) agonist with IC50 of 313 nM (rat CB1) and 41 nM (human CB2). |
|
